KRAS and neoplasm: The most frequent variant in our group was EGFR L858R, detected in 5 out of 26 (19.23%) plasma samples and in 3 out of 26 (11.53%) tumor samples, followed by the group of variants detected in codon 12 of KRAS gene (4 out of 26 or 15.38%) in plasma and tumor tissue.